Chronic urticaria is a skin condition characterized by red patches, itching and persistent swelling. When symptoms last for more than six weeks without an identifiable cause, it is referred to as chronic spontaneous urticaria. This condition can have a significant impact on quality of life due to the physical discomfort and psychological burden it creates. The Saint-Louis Research Center regularly collaborates on studies that may lead to a new treatment for chronic urticaria.
Chronic spontaneous urticaria: what is it?
Chronic urticaria is defined by the persistence of symptoms (red patches, itching, swelling) for more than six weeks. There are two main forms: chronic spontaneous urticaria and chronic inducible urticaria.
Chronic spontaneous urticaria appears without a clear or identifiable cause. Flare-ups occur unpredictably, without an obvious link to an external trigger. This is the most common form. In contrast, chronic inducible urticaria (or physical urticaria) is associated with a specific stimulus such as pressure on the skin, cold, heat, sunlight or water. In all cases, treatment aims to reduce symptoms and improve quality of life.
Treatment for chronic urticaria
Current treatments for chronic urticaria mainly aim to control symptoms. Antihistamines are the first-line option. In some cases, when antihistamines are not enough, additional treatments may be considered under medical supervision, such as certain biologic agents or short-term corticosteroids.
Despite these options, many patients continue to experience symptoms that remain resistant to standard treatments. This explains the growing interest in developing new, more targeted and better tolerated therapies.
Chronic urticaria: what new treatments are being studied?
As part of clinical research, several new treatments for chronic urticaria are currently being evaluated. These studies aim to better understand the condition and assess the safety and effectiveness of innovative molecules. Clinical studies follow rigorous protocols and are supervised by experienced healthcare teams.
These innovative treatments aim to target the inflammatory mechanisms underlying chronic urticaria. For example, some treatments may target specific pathways involved in the urticarial response. In all cases, new treatments being studied must remain confidential in order to respect strict research protocols.
New treatment for chronic urticaria: the importance of clinical research
Clinical studies, such as those conducted by the Saint-Louis Research Center in Quebec City, Montreal and Sherbrooke, are essential for advancing medical knowledge and developing safe and effective treatments. They provide a scientific evaluation of new therapeutic options before they may eventually become available to patients.
Ongoing clinical study: discovering a new treatment for chronic urticaria
Individuals interested in clinical research on chronic urticaria can review the ongoing studies at the Saint-Louis Research Center. Our team of dermatologists and healthcare professionals conducts dermatological assessments as well as rigorous follow up for each research participant. These studies are generally carried out in multiple cities, including Quebec City, Montreal and Sherbrooke.
It is important to note that participation in clinical research is voluntary and supervised, and that no new treatment for chronic urticaria can be guaranteed in advance.